Neurocrine appoints new regulatory head
This article was originally published in Scrip
Executive Summary
Neurocrine Biosciences has named Malcolm Lloyd-Smith to its executive management team as chief regulatory officer. Prior to joining San Diego, California-based Neurocrine, Mr Lloyd-Smith was senior vice-president of regulatory affairs, quality and clinical, at Cadence Pharmaceuticals.